Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Interneuron receives U.S. patent protection for stroke Rx

Sep. 15, 1998

Capsazepine attenuates inflammation-induced hyperalgesic responses

Sep. 15, 1998

Phase II trial of revolutionary migraine treatment completed ahead of schedule

Sep. 14, 1998

Roche to withdraw support for development of Kyowa Hakko's antiparkinsonian

Sep. 14, 1998

Neuroprotective effects of S-12024-2 demonstrated in rat model of neurodegeneration

Sep. 14, 1998

Synthelabo compounds act as 5-HT receptor ligands

Sep. 14, 1998

New anticonvulsant option now available in U.K.

Sep. 14, 1998

Genzyme General to commercialize and distribute Biogen's Avonex in Japan

Sep. 11, 1998

New anxiolytic PBI derivative discovered at R.W. Johnson

Sep. 11, 1998

Novel binary compounds with agonist-antagonist effects in vivo

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...